Vita 34 AG / Key word(s): Quarter Results 25.04.2013 08:29 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Vita 34 AG Improves Operating Result in Q1 2013 Leipzig, 25 April 2013 - Vita 34 AG (ISIN DE000A0BL849), the largest private umbilical cord bank in the German-speaking countries, was able to increase its periodic result in the first quarter of 2013 to EUR -20k, following EUR -210k the prior year. Thanks to cost savings, earnings before interest, taxes, depreciation and amortization, EBITDA, increased significantly to EUR 342k, as compared with EUR -27k the prior year. Revenues in the reported period were EUR 3.2 million and, therefore, were at the prior year's level. Due to the ongoing stressed economic situation in Spain, and reticence with regard to umbilical cord blood storage in Germany, the number of stem cell preparations stored in Q1 2013 totaled 1,614 and was, therefore, 6.8 percent below the figure of 1,732 in the prior year's quarter. The expansion of foreign business was continued in the reporting year, and we expanded our successful cooperation with our Serbian partner Bio Save d.o.o. to Macedonia and Bosnia-Herzegovina. The first storages from these countries are expected in the upcoming quarter. Following the first quarter, the company is confident of being able to achieve its targets for the full year 2013. Revenues are to be increased moderately, and the operating result (EBITDA) is to be increased significantly as compared with the prior year. The complete quarterly report is available for download at www.vita34group.com. Contact: Dr. André Gerth Vita 34 AG Deutscher Platz 5 04103 Leipzig Germany T: +49 341 487 9240 F: +49 341 487 9239 M: ir@vita34group.de 25.04.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Vita 34 AG Deutscher Platz 5a 04103 Leipzig Germany Phone: +49(0341)48792-40 Fax: +49(0341)48792-39 E-mail: info@vita34.de Internet: www.vita34.de ISIN: DE000A0BL849 WKN: A0BL84 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: Vita 34 AG: Vita 34 AG Improves Operating Result in Q1 2013
| Source: EQS Group AG